MIPS Molecular Imaging Program at Stanford

Sanjiv Sam Gambhir, MD, PhD

Back to Profile

Publication Details

  • The impact of PET on the management of lung cancer: the referring physician's perspective.

    Seltzer MA, Yap CS, Silverman DH, Meta J, Schiepers C, Phelps ME, Gambhir SS, Rao J, Valk PE, Czernin J. J Nucl Med. 2002; 43 (6): 752-6

    (18)F-FDG PET is a molecular whole-body imaging modality that is increasingly being used for diagnosing, staging, and restaging cancer. The objective of this study was to determine referring physicians' perspectives on the impact of (18)F-FDG PET on staging and management of lung cancer.

    PubMedID: 12050318

Stanford Medicine Resources:

Footer Links: